T he realization that nature provides the largest supply of plants blessed with medicinal properties is fascinating and worth exploring. As the world's potential plant resource has been underutilized till date, limitless opportunity exists in developing phytomedicines. The Indian subcontinent through ancient ages had followed this rich tradition of employing medicinal plants. However, these herbal medicaments suffer from major drawbacks such as lack of standardization of crude extracts and insufficient data on randomized placebo-controlled clinical studies. Consequently, skepticism regarding their efficacy cannot be ruled out. A systematic approach toward validation of such therapeutic claims has to be carried out, which will pave the way for phytotherapeutic compounds to attain scientific credibility and acceptance. Standardization of extracts which ensures a minimal level of active ingredient pertaining to a plant species is, thus, essential and of utmost importance.Liver disorders are a major cause of morbidity and a global search is on for agents which can alleviate conditions of hepatic damage. The scarcity of trustworthy contemporary liver-protecting drugs had increased the market potential of their traditional counterparts.1 Many Indian medicinal plants have been reported to have an excellent potential for the treatment of various infections and are considered as best alternatives for clinical allopathic drugs. Phyllanthus is one of the largest genus falling under kingdom Plantae, represented by around 1200 species. Until 1985, many species of Phyllanthus in India were collectively called as Phyllanthus niruri L. Surprisingly, P. niruri has been proven to be endemic to West Indies and America and has not been found to occur in India.2,3 Many phytochemical and pharmacol ogical studies reported from Indian subcontinent using P. niruri